Glutamate–Serine–Glycine Index: A Novel Potential Biomarker in Pediatric Non-Alcoholic Fatty Liver Disease
Leonetti S, Herzog RI, Caprio S, Santoro N, Tricò D. Glutamate–Serine–Glycine Index: A Novel Potential Biomarker in Pediatric Non-Alcoholic Fatty Liver Disease. Children 2020, 7: 270. PMID: 33291552, PMCID: PMC7761842, DOI: 10.3390/children7120270.Peer-Reviewed Original ResearchNon-alcoholic fatty liver diseaseAbdominal fat distributionFatty liver diseaseMagnetic resonance imagingGlycine indexLiver diseaseRisk factorsFat distributionPediatric non-alcoholic fatty liver diseasePotential biomarkersIntrahepatic fat accumulationIntrahepatic fat contentTraditional risk factorsRisk pediatric populationsBody mass indexLiver insulin resistanceTwofold higher prevalencePlasma amino acidsNovel potential biomarkersRace/ethnicityNAFLD prevalenceNAFLD patientsMass indexPediatric populationInsulin resistance